Ultralife (ULBI) Revenue (2010 - 2026)

Ultralife's Revenue history runs 17 years deep, the most recent figure standing at $47.4 million for Q1 2026.

• On a quarterly basis, Revenue fell 6.5% year-over-year to $47.4 million in Q1 2026; TTM through Mar 2026 was $187.9 million, a 8.42% increase from a year earlier, with the FY2025 full-year figure at $191.2 million, up 16.24% from the prior year.
• Revenue declined to $47.4 million in Q1 2026 per ULBI's latest filing, from $48.5 million in the prior quarter.
• Across five years, Revenue topped out at $50.7 million in Q1 2025 and bottomed at $30.4 million in Q1 2022.
• The 5-year median for Revenue is $42.7 million (2023), against an average of $40.8 million.
• Across the five-year window, Revenue jumped 52.72% in 2022 and decreased 9.61% in 2024, its largest moves.
• Year by year, Revenue stood at $36.1 million in 2022, then advanced by 23.38% to $44.5 million in 2023, then fell by 1.56% to $43.9 million in 2024, then grew by 10.56% to $48.5 million in 2025, then decreased by 2.14% to $47.4 million in 2026.
• Per Business Quant, the three latest ULBI Revenue figures stand at $47.4 million (Q1 2026), $48.5 million (Q4 2025), and $43.4 million (Q3 2025).